Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study

Comprehensive Psychiatry
Hirokazu KumazakiMasafumi Mizuno

Abstract

Remitted schizophrenic patients living in the community often encounter difficulties in their daily lives, possibly leading to the development of social anxiety symptoms. Although several studies have reported the significance of social anxiety as a comorbidity in patients with schizophrenia, few longitudinal data are available on the development of social anxiety symptoms in patients with remitted schizophrenia, especially in association with the process of "deinstitutionalization." The aims of this study were to assess the social anxiety symptoms in remitted outpatients with schizophrenia and to examine whether the development of social anxiety symptoms was associated with psychotic symptoms, social functioning, or subjective quality of life. Fifty-six people with schizophrenia who were discharged through a deinstitutionalization project were enrolled in this longitudinal study and prospectively assessed with regard to their symptoms, social functioning, and subjective quality of life. The severity of social anxiety symptoms was measured using the Liebowitz Social Anxiety Scale (LSAS). Global/Social functioning and subjective quality of life were evaluated using the Global Assessment of Functioning Scale, the Social Functioni...Continue Reading

References

May 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·M R Liebowitz
Feb 1, 1997·The American Journal of Psychiatry·J TiihonenE Leinonen
Feb 9, 2000·The Journal of Clinical Psychiatry·S PallantiA Pazzagli
Mar 4, 2000·The American Journal of Psychiatry·F R SchneierM Laruelle
Oct 31, 2002·Journal of Anxiety Disorders·Douglas S MenninMichael R Liebowitz
Jan 2, 2004·The American Journal of Psychiatry·Stefano PallantiEric Hollander
Jan 20, 2004·The Journal of Clinical Psychiatry·Julie Loebach WetherellDilip V Jeste
Nov 5, 2004·Comprehensive Psychiatry·Raphael J BragaIvan Figueira
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Apr 5, 2005·Journal of Psychiatric Research·Raphael J BragaIvan L Figueira
Aug 4, 2005·The Keio Journal of Medicine·Masafumi MizunoHaruo Kashima
Sep 21, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Alex HoferW Wolfgang Fleischhacker
Jan 19, 2007·International Journal of Mental Health Nursing·Karla Hayman-White, Brenda Happell
Oct 15, 2008·Schizophrenia Bulletin·Chunbo Li, Yanling He

❮ Previous
Next ❯

Citations

Mar 28, 2013·Current Psychiatry Reports·Stefano PallantiGiacomo Grassi
Oct 14, 2014·Comprehensive Psychiatry·Lukasz CichockiKonrad Wroński
Feb 6, 2019·The Journal of Nervous and Mental Disease·Tania LecomteAmélie Achim
Jan 28, 2020·Journal of Dual Diagnosis·Tania LecomteUNKNOWN Signature Consortium

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here